MIRA Pharmaceuticals Inc. (MIRA)
NASDAQ: MIRA
· Real-Time Price · USD
1.51
0.04 (2.72%)
At close: Aug 15, 2025, 3:59 PM
1.51
-0.01%
Pre-market: Aug 18, 2025, 08:00 AM EDT
MIRA Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Mar 31, 2021 |
Net Income | -7.92M | -7.85M | -11.24M | -12.78M | -12.36M | -11.98M | -7.54M | -5.77M | -6.92M | -7.06M | -5.71M | -3.96M | -1.53M | -56.98K |
Depreciation & Amortization | n/a | n/a | 732.29K | 732.29K | 732.29K | 732.29K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 2.3M | 1.92M | 1.37M | 2.56M | 2.69M | 2.34M | 2.48M | 1.18M | 1.44M | 1.3M | 1.15M | 1M | n/a | n/a |
Other Working Capital | -29.74K | 28.72K | -24.13K | -86.01K | -444.64K | -386.82K | -126.86K | 258.56K | 834.24K | 146.58K | -77.9K | -387.85K | -535.74K | 35.63K |
Other Non-Cash Items | 281.94K | 672.59K | 4.63M | 5.13M | 5.28M | 4.89M | 713.54K | 301.61K | 8.04K | 10.25K | 8.48K | 11.1K | 8.78K | 4.92K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 57.34K | 225.37K | -110.87K | -83.44K | -587.95K | -639.69K | -126.86K | 258.56K | 834.24K | 146.58K | -77.9K | -387.85K | -535.74K | 35.63K |
Operating Cash Flow | -6.14M | -5.56M | -5.89M | -5.81M | -5.61M | -5.63M | -4.47M | -4.03M | -4.64M | -5.6M | -4.63M | -3.33M | -2.06M | -16.42K |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | 2.22M | 2.24M | 2.02M | 2.11M | -133.06K | -133.06K | 86.48K | -50K | -50K | -50K | -50K | n/a |
Common Stock Repurchased | n/a | n/a | -1.35K | -1.35K | -1.35K | -1.35K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 3.34M | 3.31M | 3.29M | -1.33M | -808.8K | -145.27K | 727.88K | 1.95M | 1.11M | 292.19K | -561.81K | -321.34K | -161.34K | 16.89K |
Financial Cash Flow | 3.82M | 3.79M | 4.17M | 8.61M | 9.13M | 9.88M | 10.15M | 3.23M | 2.52M | 3.15M | 2.01M | 1.35M | 1.37M | 16.89K |
Net Cash Flow | -2.32M | -1.77M | -1.72M | 2.8M | 3.53M | 4.25M | 5.68M | -801.16K | -2.12M | -2.46M | -2.62M | -1.98M | -686.32K | 469.00 |
Free Cash Flow | -6.14M | -5.56M | -5.89M | -5.81M | -5.61M | -5.63M | -4.47M | -4.03M | -4.64M | -5.6M | -4.63M | -3.33M | -2.06M | -16.42K |